ALX Oncology Holdings Inc (ALXO)
1.515
+0.02
(+1.68%)
USD |
NASDAQ |
Nov 05, 16:00
1.53
+0.02
(+0.99%)
After-Hours: 18:51
ALX Oncology Holdings Market Cap: 79.80M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 78.48M |
| November 01, 2024 | 76.37M |
| October 31, 2024 | 75.32M |
| October 30, 2024 | 72.69M |
| October 29, 2024 | 73.74M |
| October 28, 2024 | 76.90M |
| October 25, 2024 | 77.43M |
| October 24, 2024 | 76.64M |
| October 23, 2024 | 87.44M |
| October 22, 2024 | 79.01M |
| October 21, 2024 | 79.01M |
| October 18, 2024 | 77.95M |
| October 17, 2024 | 79.53M |
| October 16, 2024 | 82.17M |
| October 15, 2024 | 82.17M |
| October 14, 2024 | 81.64M |
| October 11, 2024 | 81.11M |
| October 10, 2024 | 75.85M |
| October 09, 2024 | 85.33M |
| October 08, 2024 | 86.91M |
| October 07, 2024 | 83.75M |
| October 04, 2024 | 88.49M |
| October 03, 2024 | 90.60M |
| October 02, 2024 | 96.39M |
| October 01, 2024 | 97.97M |
| Date | Value |
|---|---|
| September 30, 2024 | 95.86M |
| September 27, 2024 | 103.76M |
| September 26, 2024 | 98.50M |
| September 25, 2024 | 95.34M |
| September 24, 2024 | 102.71M |
| September 23, 2024 | 104.82M |
| September 20, 2024 | 109.03M |
| September 19, 2024 | 114.30M |
| September 18, 2024 | 112.72M |
| September 17, 2024 | 114.82M |
| September 16, 2024 | 114.82M |
| September 13, 2024 | 116.93M |
| September 12, 2024 | 112.72M |
| September 11, 2024 | 114.82M |
| September 10, 2024 | 113.77M |
| September 09, 2024 | 110.61M |
| September 06, 2024 | 100.60M |
| September 05, 2024 | 104.82M |
| September 04, 2024 | 108.50M |
| September 03, 2024 | 112.72M |
| August 30, 2024 | 122.20M |
| August 29, 2024 | 121.15M |
| August 28, 2024 | 123.25M |
| August 27, 2024 | 131.15M |
| August 26, 2024 | 135.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
72.69M
Minimum
Oct 30 2024
4.166B
Maximum
Dec 10 2020
1.063B
Average
598.77M
Median
Market Cap Benchmarks
| Biomarin Pharmaceutical Inc | 12.59B |
| Neurocrine Biosciences Inc | 12.30B |
| Eton Pharmaceuticals Inc | 214.70M |
| Verve Therapeutics Inc | 537.37M |
| Immuneering Corp | 58.71M |
Market Cap Related Metrics
| PS Ratio | 19.93 |
| Price to Book Value | 0.5009 |
| Price | 1.515 |
| Earnings Yield | -239.6% |